Latest Breaking News On - Fite vp drug development - Page 1 : comparemela.com

FDA encouraged the Company to accelerate enrollment of adolescent patients due to Piclidenoson’s good safety profile There is an unmet need for safe, convenient, and effective drugs to treat.

United statesWilliam kernsFite biopharma ltdEuropean medicines agencyFite vp drug developmentDrug administrationCan fite biopharmaPediatric study planFite biopharmaOrphan drug designationFast track designationAnnual report